Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF

NCT07181590 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT07181590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07181590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Recruiting
Start date
December 11, 2025
Completion date
August 31, 2027
Enrollment
300 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

atrial arrhythmia, atrial fibrillation, paroxysmal af, persistent atrial fibrillation